- Home
- FLYE vs PYPD Comparison
FLYE vs PYPD Comparison
Compare FLYE & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYE
- PYPD
- Stock Information
- Founded
- FLYE 2018
- PYPD 2008
- Country
- FLYE United States
- PYPD Israel
- Employees
- FLYE N/A
- PYPD N/A
- Industry
- FLYE Aerospace
- PYPD Medical/Dental Instruments
- Sector
- FLYE Industrials
- PYPD Health Care
- Exchange
- FLYE Nasdaq
- PYPD Nasdaq
- Market Cap
- FLYE 10.9M
- PYPD 19.4M
- IPO Year
- FLYE 2024
- PYPD 2020
- Fundamental
- Price
- FLYE $0.70
- PYPD $2.94
- Analyst Decision
- FLYE
- PYPD Strong Buy
- Analyst Count
- FLYE 0
- PYPD 2
- Target Price
- FLYE N/A
- PYPD $10.50
- AVG Volume (30 Days)
- FLYE 265.1K
- PYPD 43.8K
- Earning Date
- FLYE 02-10-2025
- PYPD 02-12-2025
- Dividend Yield
- FLYE N/A
- PYPD N/A
- EPS Growth
- FLYE N/A
- PYPD N/A
- EPS
- FLYE N/A
- PYPD N/A
- Revenue
- FLYE $30,297,313.00
- PYPD N/A
- Revenue This Year
- FLYE N/A
- PYPD N/A
- Revenue Next Year
- FLYE N/A
- PYPD N/A
- P/E Ratio
- FLYE N/A
- PYPD N/A
- Revenue Growth
- FLYE 14.77
- PYPD N/A
- 52 Week Low
- FLYE $0.38
- PYPD $2.37
- 52 Week High
- FLYE $7.62
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- FLYE N/A
- PYPD 44.37
- Support Level
- FLYE N/A
- PYPD $2.60
- Resistance Level
- FLYE N/A
- PYPD $3.85
- Average True Range (ATR)
- FLYE 0.00
- PYPD 0.38
- MACD
- FLYE 0.00
- PYPD 0.01
- Stochastic Oscillator
- FLYE 0.00
- PYPD 27.03
About FLYE Fly-E Group Inc. Common Stock
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.